Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis
Proceedings of the National Academy of Sciences · 11.06.2024 · 121 (24)
DOI: 10.1073/pnas.2404668121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 04.06.2024. Verfasst von Ke-Bin Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for G…. Hauptthemen laut MEDLINE: Copper, Oxidation-Reduction, Homeostasis, Glutathione. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Natural Natural Science Foundation of Guangxi Province, Welch.
Abstract (Originalsprache)
Developing anticancer drugs with low side effects is an ongoing challenge. Immunogenic cell death (ICD) has received extensive attention as a potential synergistic modality for cancer immunotherapy. However, only a limited set of drugs or treatment modalities can trigger an ICD response and none of them have cytotoxic selectivity. This provides an incentive to explore strategies that might provide more effective ICD inducers free of adverse side effects. Here, we report a metal-based complex ( Cu-1 ) that disrupts cellular redox homeostasis and effectively stimulates an antitumor immune response with high cytotoxic specificity. Upon entering tumor cells, this Cu(II) complex enhances the production of intracellular radical oxidative species while concurrently depleting glutathione (GSH). As the result of heightening cellular oxidative stress, Cu-1 gives rise to a relatively high cytotoxicity to cancer cells, whereas normal cells with low levels of GSH are relatively unaffected. The present Cu(II) complex initiates a potent ferroptosis-dependent ICD response and effectively inhibits in vivo tumor growth in an animal model (c57BL/6 mice challenged with colorectal cancer). This study presents a strategy to develop metal-based drugs that could synergistically potentiate cytotoxic selectivity and promote apoptosis-independent ICD responses through perturbations in redox homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Science…
- Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Science, Sun Yat-Sen University, Guangzhou 510006, China.
- Department of Chemistry, The University of Texas at Austin, Austin, TX 78712-1224.
ORCID-Profile: Taotao Zou, Jonathan L Sessler
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Natural Natural Science Foundation of Guangxi Province
- Welch
Zitieren
APA
Huang, K. B., Wang, F. Y., Lu, Y., Yang, L. M., Long, N., Wang, S. S., Xie, Z., Levine, M., Zou, T., Sessler, J. L., & Liang, H. (2024). Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis. Proceedings of the National Academy of Sciences, 121(24). https://doi.org/10.1073/pnas.2404668121
Vancouver
Huang KB, Wang FY, Lu Y, Yang LM, Long N, Wang SS, et al. Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis. Proceedings of the National Academy of Sciences. 2024;121(24). doi:10.1073/pnas.2404668121
BibTeX
@article{Huang2024,
author = {Huang, Ke-Bin and Wang, Feng-Yang and Lu, Yuan and Yang, Liang-Mei and Long, Nian and Wang, Shan-Shan and Xie, Zhiying and Levine, Matthew and Zou, Taotao and Sessler, Jonathan L and Liang, Hong},
title = {Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {24},
doi = {10.1073/pnas.2404668121}
}
EUVIMED